Prognostic factors for survival in multiple sclerosis

Area of Science:

• Neurology
• Clinical Research
• Prognostic Studies

Background:

• Multiple Sclerosis (MS) is a chronic, unpredictable neurological disease.
• Accurate long-term prognosis is crucial for patient management and treatment planning.
• Identifying early prognostic factors can improve clinical decision-making.

Purpose of the Study:

• To identify demographic and clinical factors predicting long-term prognosis in multiple sclerosis.
• To analyze the validity of these factors in a hospital-based cohort.
• To differentiate prognostic indicators across different MS disease courses.

Main Methods:

• Hospital-based study of 119 patients with definite multiple sclerosis.
• Mean follow-up period of 21.7 years.
• Univariate and multivariate analyses of demographic and clinical factors.

Main Results:

• Univariate analysis identified male sex, age >25 at onset, pyramidal/spasticity involvement, multiple functional systems affected, incomplete/short first remission, frequent attacks, progressive disease, and time to reach EDSS 6 as negative prognostic factors.
• Multivariate analysis in relapsing-remitting MS showed pyramidal involvement and shorter time to EDSS 6 predicted poor outcome at 5 years; older age at onset and incomplete remission predicted poor prognosis at 10 years.
• In progressive MS, predictors of poor outcome included time to EDSS 6/secondary progression and higher EDSS (secondary-progressive), and spasticity/multiple functional systems affected and higher EDSS (primary-progressive).

Conclusions:

• Early clinical and demographic factors significantly influence multiple sclerosis long-term prognosis.
• Prognostic indicators vary depending on the disease course (relapsing-remitting vs. progressive).
• The study provides a comprehensive analysis of predictors for long-term outcomes in MS.